Research

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

SARS-CoV-2 within-host diversity and transmission

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Structural impact on SARS-CoV-2 spike protein by D614G substitution

Prevalence of mental disorders, suicidal ideation and suicides in the general population before and during the COVID-19 pandemic in Norway: A population-based repeated cross-sectional analysis

Spread of a variant SARS-CoV-2 in long-term care facilities in England

Tocilizumab in hospitalized patients with severe COVID-19 pneumonia

Interleukin-6 Receptor antagonists in critically ill patients with COVID-19

Antibody responses in seropositive persons after a single dose of SARS-CoV-2 mRNA vaccine

BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting

Efficacy of the ChAdOx1 nCoV-19 COVID-19 vaccine against the B.1.351 variant

Paper of the month: Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin

For April 2021, we have selected: Pun B.T. et al. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study. Lancet Respir Med. 2021; 9:239-250. doi: 10.1016/S2213-2600(20)30552-X.

The fifth episode of the podcast series “One Voice for Neurology” focuses on research in neuroscience. Three guests have been interviewed: Prof. Monica di Luca, president of the European Brain Council, Jane Ransom, executive director of the American Brain Foundation and Dr. Paulo Fontoura, Global Head of Clinical Development Neuroscience at Roche.